Survival analysis also display that 5-year OS and 5-year DFS of patients with high TRIM24 level are 64.4% and 57.2%, compared with 35.8% and 28.9% of those with low level, respectively, which hint that TRIM24 is a tumor suppressor in ESCC patients. Here, TRIM24 is linked to esophageal squamous cell carcinoma.